An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir-grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study).
Bronowicki JP, Miailhes P, Hanslik B, Ouzan D, Larrey D, Riachi G, Truchi R, Jouannaud V, Pospait D, Abergel A, Causse X, Perot S, Skrzypski J, De Hautecloque A, Spampinato A, Mariot P, Sogni P; Zephyr Study group.
Bronowicki JP, et al. Among authors: perot s.
Health Sci Rep. 2022 Dec 5;6(1):e619. doi: 10.1002/hsr2.619. eCollection 2023 Jan.
Health Sci Rep. 2022.
PMID: 36479389
Free PMC article.